| 8962020 |
Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid |
Clyde W. Shearman |
2015-02-24 |
| 6552077 |
Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
— |
2003-04-22 |
| 6355680 |
Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies |
— |
2002-03-12 |
| 6001875 |
In vivo methods of treatment to prevent kidney dysfunction using substances that inhibit albumin glycation |
Rex Clements |
1999-12-14 |
| 5994401 |
In Vivo Methods to reduce hypercholesterolemia and improve vascular dysfunction |
Rex Clements |
1999-11-30 |
| 5908925 |
Genetically engineered immunoglobulins with specificity for glycated albumin |
Clyde W. Shearman |
1999-06-01 |
| 5518720 |
Treatment of complications of diabetes with substances reactive with the fructosyl-lysine structure in glycated albumin |
— |
1996-05-21 |
| 5494791 |
Monoclonal antibodies against glycated low density lipoprotein |
— |
1996-02-27 |
| 5312628 |
Isolation of a soluble 42 KD pancreatic islet cell autoantigen |
Van-Yu Wu |
1994-05-17 |
| 5223392 |
Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore |
— |
1993-06-29 |
| 5183739 |
Monoclonal antibodies specific for non-A1C glycated hemoglobin and immunoassay methods |
— |
1993-02-02 |